pfizer covid vaccine - Search News

News

COVID-19, FDA and vaccine

Forbes on MSN · 2h

FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.”

CBS News on MSN · 5h

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk," the agency said in an article published by The New England Journal of Medicine, authored by FDA Commissioner Dr. Martin Makary and his new top vaccines official, Dr. Vinay Prasad.

MedPage Today · 57m

FDA Panel to Consider COVID Vaccine Makeup for Next Season

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using monovalent JN.1- or KP.2-lineage COVID-19 vaccine formulations -- the same as last year's -- with monovalent LP.8.1 lineage as a suitable alternative formulation.

4h

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

3d

Pfizer scientist claimed COVID vax results being delayed until after 2020 election ‘wasn’t a coincidence’: House GOP panel

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...

4don MSN

House GOP requests records from Pfizer CEO and former executive in probe of Covid vaccine delay allegation

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

1don MSN

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

By Kamal Choudhury (Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results